hepg2 cells (CLS Cell Lines Service GmbH)
CLS Cell Lines Service GmbH is a verified supplier 
CLS Cell Lines Service GmbH manufactures this product 
95
Structured Review
CLS Cell Lines Service GmbH
hepg2 cells
Hepg2 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 95/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/HepG2+Cells/custom%40300198%4042692359
Average 95 stars, based on 152 article reviews
Hepg2 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 95/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/HepG2+Cells/custom%40300198%4042692359
Average 95 stars, based on 152 article reviews
hepg2 cells - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Reporter Assay:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Transfection:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Cell Culture:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Luciferase:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Thin Layer Chromatography:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Modification:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Variant Assay:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Phospho-proteomics:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Gene Expression:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Targeted Gene Expression:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Expressing:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Mutagenesis:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 Stable Transfection:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 In Vitro:Article Title: IL-13 ameliorates hepatocellular steatosis via IL-13Rα1/JNK/FOSL2 signaling pathway. Article Snippet: l acetic acid 22:3 (V/V), blue nozzle, spraying level 3; TLC Plate Heater, 105 °C, 5 min) to 545 distinguish from coeluted phosphatidylinositol. 546 547 Dual-Luciferase Reporter Assay 548 |
